Exagen Inc. (XGN) stock
XGNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3010% above fair value
$3.90+0.14 (+3.72%)
Close on Nov 18, 2026Market cap $94.48MP/E –Yield –
Exagen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Exagen's market cap was $121.81M on Nov 11, 2026, against $177.83M a year earlier. Over the last 5 years it ranged from $23.62M to $256.73M, with a median of $69.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $121.81M | -11.0% |
| 2025 | Dec 31, 2025 | $136.86M | +90.5% |
| 2024 | Dec 31, 2024 | $71.83M | +113.2% |
| 2023 | Dec 29, 2023 | $33.69M | -13.9% |
| 2022 | Dec 30, 2022 | $39.13M | -79.2% |
| 2021 | Dec 31, 2021 | $187.99M | +12.6% |
| 2020 | Dec 31, 2020 | $167.01M | -47.6% |
| 2019 | Dec 31, 2019 | $319.01M | – |
See a number that looks wrong?